Literature DB >> 13376711

Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms.

L D MACLEAN, W W SPINK, M B VISSCHER, M H WEIL.   

Abstract

Entities:  

Keywords:  BACTERIA; BLOOD CIRCULATION/effect of drugs on

Mesh：

Substances：

Year:  1956        PMID： 13376711      PMCID： PMC441695          DOI： 10.1172/JCI103373

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  14 in total

1.  Studies with radioactive endotoxin. I. The use of Cr51 to label endotoxin of Escherichia coli.

Authors:  A I BRAUDE; F J CAREY; D SUTHERLAND; M ZALESKY
Journal:  J Clin Invest       Date:  1955-06       Impact factor: 14.808

2.  Shock associated with bacteremia; review of thirty-five cases.

Authors:  W H HALL; D GOLD
Journal:  AMA Arch Intern Med       Date:  1955-09

3.  HEMODYNAMIC ALTERATIONS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS DURING THE PYROGENIC REACTION.

Authors:  S E Bradley; H Chasis; W Goldring; H W Smith
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

4.  CIRCULATORY FAILURE IN ACUTE INFECTIONS.

Authors:  R V Ebert; E A Stead
Journal:  J Clin Invest       Date:  1941-11       Impact factor: 14.808

5.  Small vein and artery pressures in normal and edematous extremities of dogs under local and general anesthesia.

Authors:  F J HADDY; A G RICHARDS; J L ALDEN; M B VISSCHER
Journal:  Am J Physiol       Date:  1954-02

6.  Estimation of cardiac output and Evans blue space in man, using an oximeter.

Authors:  J W NICHOLSON; E H WOOD
Journal:  J Lab Clin Med       Date:  1951-10

7.  The oxygenation of blood by gas dispersion.

Authors:  L C CLARK; F GOLLAN; V B GUPTA
Journal:  Science       Date:  1950-01-27       Impact factor: 47.728

8.  Clinical studies on a vasopressor agent: metaraminol (aramine). II. Observations on its use in the management of shock.

Authors:  M H WEIL
Journal:  Am J Med Sci       Date:  1955-10       Impact factor: 2.378

9.  The pathogenesis of experimental dysentery intoxication; production of the lesions by cerebral circulation of the toxin.

Authors:  A PENNER; S H KLEIN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

10.  Studies on the generalized Shwartzman reaction: I. General observations concerning the phenomenon.

Authors:  L THOMAS; R A GOOD
Journal:  J Exp Med       Date:  1952-12       Impact factor: 14.307
View more
  41 in total

1.  BACTERIAEMIC SHOCK.

Authors:  H I GLASS; H D ROWAN; W STEVENSON
Journal:  Br Med J       Date:  1964-02-01

2.  THE INITIAL STAGE OF CANINE ENDOTOXIN SHOCK AS AN EXPRESSION OF ANAPHYLACTIC SHOCK: STUDIES ON COMPLEMENT TITERS AND PLASMA HISTAMINE CONCENTRATIONS.

Authors:  W W SPINK; R B DAVIS; R POTTER; S CHARTRAND
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

3.  ENDOTOXIN SHOCK WITH MASSIVE ADRENAL HEMORRHAGE.

Authors:  G KAPLAN
Journal:  Calif Med       Date:  1965-03

4.  Treatment of endotoxic shock--the dilemma of vasopressor and vasodilator therapy.

Authors:  M H WEIL; R B SUDRANN; H SHUBIN
Journal:  Calif Med       Date:  1962-02

5.  Small intestinal blood flow.

Authors:  E C TEXTER
Journal:  Am J Dig Dis       Date:  1963-07

6.  Hemodynamic alterations due to Salmonella typhosa endotoxin with special reference to the coronary vascular bed.

Authors:  E D FROHLICH; J B SCOTT; E S DOOLEY
Journal:  J Clin Invest       Date:  1962-01       Impact factor: 14.808

7.  Histamine release and endotoxin shock in the primate.

Authors:  L B HINSHAW; M M JORDAN; J A VICK
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

8.  Disseminated intravascular coagulation: a cause of shock.

Authors:  R M HARDAWAY; D G McKAY
Journal:  Ann Surg       Date:  1959-04       Impact factor: 12.969

9.  Studies on the absorption of Escherichia coli endotoxin from the gastrointestinal tract of dogs in the pathogenesis of irreversible hemorrhagic shock.

Authors:  J P SANFORD; H E NOYES
Journal:  J Clin Invest       Date:  1958-10       Impact factor: 14.808

10.  A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.

Authors:  J E Parrillo; C Burch; J H Shelhamer; M M Parker; C Natanson; W Schuette
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.